C12Y 501/03017
Heparosan-n-sulfate-glucuronate 5-epimerase
Official title: Heparosan-N-sulfate-glucuronate 5-epimerase (5.1.3.17)
C12Y501/03017 (Heparosan-n-sulfate-glucuronate 5-epimerase) appears on 4 US grants and 9 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 9
- Assignees
- 8
- Inventors
- 21
- Latest grant
- 1 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 2 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 3 | 3 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for producing sulfated polysaccharide and method for producing PAPS1 Apr 2025US 12,264,350 B2Kirin Biomaterials Co., Ltd.
- Method for producing heparosan compound having isomerized hexuronic acid residue2 May 2023US 11,639,513 B2Ajinomoto Co., Inc.
- Methods for synthesizing anticoagulant polysaccharides18 Apr 2023US 11,629,364 B2Optimvia, LLC
- Methods for synthesizing anticoagulant polysaccharides3 Jan 2023US 11,542,534 B2Optimvia, LLC
- Methods of Production of Heparosan, Heparan Sulfate and Heparin in Yeast18 Jun 2026US 2026/0168001 A1Genhtis Fine Chemicals GmbH
- Method for producing sulfated polysaccharide and method for producing paps31 Jul 2025US 2025/0243524 A1Kirin Biomaterials Co., Ltd.
- Heparosan-producing recombinant cells12 Dec 2024US 2024/0409973 A1Givaudan SA
- Methods for synthesizing anticoagulant polysaccharides26 Oct 2023US 2023/0340552 A1Optimvia, LLC
- Method for producing sulfated polysaccharide and method for producing paps25 May 2023US 2023/0159969 A1Kirin Biomaterials Co., Ltd.
Most cited
By later US patents